vs
ASP Isotopes Inc.（ASPI）与FrontView REIT, Inc.（FVR）财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是FrontView REIT, Inc.的1.0倍（$16.7M vs $16.5M）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
ASPI vs FVR — 直观对比
营收规模更大
ASPI
是对方的1.0倍
$16.5M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $16.5M |
| 净利润 | — | $-4.1M |
| 毛利率 | 12.5% | — |
| 营业利润率 | — | — |
| 净利率 | — | -24.9% |
| 营收同比 | 1295.7% | — |
| 净利润同比 | -586.8% | — |
| 每股收益（稀释后） | — | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPIFVR
| Q4 25 | $16.7M | $16.5M | ||
| Q3 25 | $4.9M | $16.8M | ||
| Q2 25 | — | $17.6M | ||
| Q1 25 | — | $16.2M | ||
| Q3 24 | — | $14.5M |
净利润ASPIFVR
| Q4 25 | — | $-4.1M | ||
| Q3 25 | $-12.9M | $4.0M | ||
| Q2 25 | — | $-2.9M | ||
| Q1 25 | — | $-833.0K | ||
| Q3 24 | — | $-2.4M |
毛利率ASPIFVR
| Q4 25 | 12.5% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
营业利润率ASPIFVR
| Q4 25 | — | — | ||
| Q3 25 | -306.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
净利率ASPIFVR
| Q4 25 | — | -24.9% | ||
| Q3 25 | -263.7% | 23.9% | ||
| Q2 25 | — | -16.5% | ||
| Q1 25 | — | -5.1% | ||
| Q3 24 | — | -16.7% |
每股收益（稀释后）ASPIFVR
| Q4 25 | — | $-0.19 | ||
| Q3 25 | $-0.15 | $0.19 | ||
| Q2 25 | — | $-0.16 | ||
| Q1 25 | — | $-0.06 | ||
| Q3 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $13.5M |
| 总债务越低越好 | $14.4M | $314.3M |
| 股东权益账面价值 | $204.2M | $391.2M |
| 总资产 | $498.0M | $854.4M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.80× |
8季度趋势，按日历期对齐
现金及短期投资ASPIFVR
| Q4 25 | $333.3M | $13.5M | ||
| Q3 25 | $113.9M | $19.6M | ||
| Q2 25 | — | $8.4M | ||
| Q1 25 | — | $3.3M | ||
| Q3 24 | — | — |
总债务ASPIFVR
| Q4 25 | $14.4M | $314.3M | ||
| Q3 25 | $13.9M | $307.1M | ||
| Q2 25 | — | $316.9M | ||
| Q1 25 | — | $310.2M | ||
| Q3 24 | — | — |
股东权益ASPIFVR
| Q4 25 | $204.2M | $391.2M | ||
| Q3 25 | $74.1M | $385.2M | ||
| Q2 25 | — | $369.9M | ||
| Q1 25 | — | $324.7M | ||
| Q3 24 | — | $1.0K |
总资产ASPIFVR
| Q4 25 | $498.0M | $854.4M | ||
| Q3 25 | $225.9M | $846.8M | ||
| Q2 25 | — | $856.5M | ||
| Q1 25 | — | $860.8M | ||
| Q3 24 | — | $1.0K |
负债/权益比ASPIFVR
| Q4 25 | 0.07× | 0.80× | ||
| Q3 25 | 0.19× | 0.80× | ||
| Q2 25 | — | 0.86× | ||
| Q1 25 | — | 0.96× | ||
| Q3 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $42.1M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | — |
| 自由现金流率自由现金流/营收 | -284.7% | — |
| 资本支出强度资本支出/营收 | 57.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASPIFVR
| Q4 25 | $-37.8M | $42.1M | ||
| Q3 25 | $-8.9M | $8.3M | ||
| Q2 25 | — | $9.3M | ||
| Q1 25 | — | $8.1M | ||
| Q3 24 | — | — |
自由现金流ASPIFVR
| Q4 25 | $-47.4M | — | ||
| Q3 25 | $-12.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
自由现金流率ASPIFVR
| Q4 25 | -284.7% | — | ||
| Q3 25 | -245.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
资本支出强度ASPIFVR
| Q4 25 | 57.9% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
现金转化率ASPIFVR
| Q4 25 | — | — | ||
| Q3 25 | — | 2.06× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
